Category: Benzinga

Post
Petrobras Cuts Refinery Diesel Prices Again, Puts Amazon Basin Potash Rights On Sale

Petrobras Cuts Refinery Diesel Prices Again, Puts Amazon Basin Potash Rights On Sale

Brazilian state-run Petroleo Brasileiro (NYSE: PBR), also known as Petrobras, will lower refinery gate diesel prices by almost 4% from today, marking the second cut in a week after a drop in international prices. The company said it would cut diesel prices to 5.19 reais ($1.01) from 5.41 reais, while gasoline prices were kept unchanged. The oil giant had already lowered diesel...

Post
Schwazze Q2 Revenue Grows 44% YoY, What About Profit?

Schwazze Q2 Revenue Grows 44% YoY, What About Profit?

Schwazze, (OTCQX: SHWZ) (NEO:SHWZ) released financial results for the second quarter ended June 30, 2022, revealing revenues of $44.3 million, an increase of 44% compared to $30.7 million in Q2 2021. Q2 2022 Financial Highlights: Gross profit increased to $25.2 million, an increase of 69% compared to $14.9 million during the same period in 2021....

Post
Illumina, CS Disco And Some Other Big Stocks Moving Lower In Today's Pre-Market Session

Illumina, CS Disco And Some Other Big Stocks Moving Lower In Today's Pre-Market Session

Olo Inc. (NYSE: OLO) shares fell 31.7% to $8.87 in pre-market trading after the company reported Q2 results and issued FY22 guidance below consensus estimates. CS Disco, Inc. (NYSE: LAW) fell 27.8% to $20.90 in pre-market trading after the company reported worse-than-expected Q2 EPS and issued weak Q3 guidance. Co-Diagnostics, Inc. (NASDAQ: CODX) shares fell...

Post
$10 Million Bet On This Energy Stock? 4 Stocks Insiders Are Buying

$10 Million Bet On This Energy Stock? 4 Stocks Insiders Are Buying

Although US stocks closed mixed on Thursday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the...

Post
Dogecoin Daily: Price Dampens, Co-Founder Says 'Crypto Acting Like It's 2021'

Dogecoin Daily: Price Dampens, Co-Founder Says 'Crypto Acting Like It's 2021'

Dogecoin (CRYPTO: DOGE) traded 1.45% lower at $0.07 over 24 hours leading up to early Friday morning. DOGE traded lower alongside larger coins as the global cryptocurrency market cap fell 1.7% to $1.15 trillion. Dogecoin Price Performance Time-frame % Change (+/-) 24-hour -1.45% 24-hour against Bitcoin 1.1% 24-hour against Ethereum -1.3% 7-day 17% 30-day 4.35%...

Post
Investor Optimism Rises Slightly Following PPI Data

Investor Optimism Rises Slightly Following PPI Data

The CNN Money Fear and Greed index showed slight improvement in overall market optimism following the release of another inflation data. The index, meanwhile, remained in the "neutral" zone on Friday. Producer prices for the U.S. dropped 0.5% month-over-month in July, following a revised 1% increase in the previous month. Analysts, on the other hand,...

Post
Why Is Toast Trading Higher By 20%: Here Are 34 Stocks Moving Premarket

Why Is Toast Trading Higher By 20%: Here Are 34 Stocks Moving Premarket

Gainers Neptune Wellness Solutions Inc. (NASDAQ: NEPT) shares rose 66.9% to $2.37 in pre-market trading. Neptune Wellness Solutions recently announced voluntary delisting from Toronto Stock Exchange. Larimar Therapeutics, Inc. (NASDAQ: LRMR) shares rose 37.4% to $2.72 in pre-market trading after the company received meeting minutes from the FDA following a recent Type C Meeting to...

Post
Cerevel Therapeutics Announces Pricing of $300 Million Private Offering of Convertible Senior Notes and Concurrent $254 Million Public Offering of Common Stock

Cerevel Therapeutics Announces Pricing of $300 Million Private Offering of Convertible Senior Notes and Concurrent $254 Million Public Offering of Common Stock

CAMBRIDGE, Mass., Aug. 12, 2022 (GLOBE NEWSWIRE) — Cerevel Therapeutics Holdings, Inc. (“Cerevel”, “we”, “us” or “our”) (NASDAQ:CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today the pricing of its previously announced private offering of $300.0 million aggregate principal amount of 2.50% convertible senior notes due 2027...